Federation Bio Competitors and Similar CompaniesClear all
Federation Bio's competitors and similar companies include Applied Genetic Technologies, Menlo Therapeutics, ArunA Bio and Chondrial Therapeutics.
 Applied Genetic Technologies Applied Genetic Technologies is a clinical-stage biotechnology company, which develops gene therapy products designed to manage the lives of patients with severe diseases in ophthalmology. |  Menlo Therapeutics Menlo Therapeutics is a clinical stage pharmaceutical company dedicated to the development of serlopitant. |  ArunA Bio ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules. |  Chondrial Therapeutics Chondrial Therapeutics is engaged in discovering and developing orphan drugs for mitochondrial diseases. | ||
Founding Date | Founding Date 2018 | Founding Date 1991 | Founding Date 2011 | Founding Date 2003 | Founding Date 2013 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations South San Francisco, US HQ | Locations Alachua, US HQ Cambridge, US | Locations Redwood City, US HQ Ness Ziona, IL Bridgewater Township, US | Locations Athens, US HQ Athens, US | Locations Bala Cynwyd, US HQ Indianapolis, US |
Employees | Employees 2318% decrease | Employees 859% increase | Employees 26 | Employees 274% increase | Employees 736% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 16.9 m | Valuation ($) 39.7 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $325k (FY, 2022) | Revenue (est.) $570k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($68.9m) (FY, 2022) | Net income ($26.5m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 50m (over 5 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 4.5m (over 6 years ago) | Latest funding round $ 22.6m (over 9 years ago) |
Total funding raised | Total funding raised $ 50m | Total funding raised $ 70.7m | Total funding raised $ 50m | Total funding raised $ 26.9m | Total funding raised $ 23.6m |
For sources of this data, please see the company profile
View Company Profiles
Applied Genetic Technologies
HQ
Alachua, US
Employees
85↑ 9% increase
Applied Genetic Technologies is a clinical-stage biotechnology company, which develops gene therapy products designed to manage the lives of patients with severe diseases in ophthalmology.
View companyMenlo Therapeutics
HQ
Redwood City, US
Employees
26
Menlo Therapeutics is a clinical stage pharmaceutical company dedicated to the development of serlopitant.
View companyArunA Bio
HQ
Athens, US
Employees
27↑ 4% increase
ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules.
View companyChondrial Therapeutics
HQ
Bala Cynwyd, US
Employees
73↑ 6% increase
Chondrial Therapeutics is engaged in discovering and developing orphan drugs for mitochondrial diseases.
View company